---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "YP6qxwVh4nQz0cSQcS86R42mmqM8nwnxREVtOICPasIGursVV+KVkGuKPxpOyBzioiGcs4LSRv0UXts5Uwlq4LqUhGdMlVDJzqvHEI2c5Cj3V050AD7ymMxGaXb1OQ+iHApNwz7Z1k84BudE/bTbLRJAwNK44VzTD45jKxVR5VU50icY/l2wno20fpzuUfUO+nJaiI6lbzjL75PG8cCrNIT04Khgalw+Yuyt/x11VbgK4e47TuHD12UnVZUbSzxLlbOydS0scMcfXyduXiSV4uMPLNPzZVH+6xIke8xbi05Voib1ybCQNKUOj6OyRgVF90HI/kLH5XYsIEeGXXFTdC8hNXojXMJ3uDuJK7z4OrY=;VR1GpxtJK3tDY2taDA3NYQ=="
---

